The present invention regards an impurity of lapatinib, N-{3-chloro-4-[(2-fluorobynzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)furan-2-yl] quinazoline-4-amine compound of formula (I) or a salt thereof:the analytical methods for identifying it and quantifying it in Lapatinib and salts thereof.The invention also regards Lapatinib comprising less than 0.05 percent of this impurity and the relative method of preparation.